Bei Naga Markets registrieren
UCB, BE0003739530

UCB stock pre-market at EUR 203.40

Published on 10/13/2026 at 08:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UCB stock is at EUR 203.40 pre-market at Lang & Schwarz on October 13, 2026. UCB’s investor materials list several upcoming clinical milestones.

  • UCB stock is at EUR 203.40 pre-market at Lang & Schwarz.
  • UCB’s pipeline lists bimekizumab topline results for H1 2027.
  • The 52-week high is EUR 289.50 and the P/E ratio is 18.03.
Moderner Biopharma-Forschungscampus mit Glasgebäuden und Laborpersonal in Brüssel bei Tageslicht
UCB S.A. mit ISIN BE0003739530 zeigt modernen Forschungscampus in Brüssel mit Laborpersonal in Glasgebäuden, Illustration mit AI erstellt.

UCB stock is at EUR 203.40 at Lang & Schwarz at 8:12 a.m. CEST on October 13, 2026, ahead of the 9:00 a.m. Xetra open.

Pre-market price

The Lang & Schwarz bid is EUR 203.00 and the ask is EUR 203.80. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of UCB stock.

What matters today

UCB’s investor materials list topline results for bimekizumab in H1 2027, according to the company’s investor-relations website. The stock’s 52-week high was EUR 289.50 on October 12, 2026, EUR 86.10 above the current price, according to MarketWatch. UCB’s P/E ratio was 18.03 on October 12, 2026, the same source reported.

Market context: Market report Euro Stoxx 50.

More news and analysis on UCB stock

Disclaimer...

en | BE0003739530 | UCB | boerse | 70310042 | bgmi